And silencing ATAD2 inhibits the proliferation of gastric cancer cells by reducing the expression of the key cell cycle regulator proteins cyclin D1, Rb, E2F1 and cyclin E, thereby arresting the cell cycle in the G1/S phase 40(Figure 3D). Here, ATAD2 is linked to gastric cancer.